
Advances in the Treatment of Autoimmune Nodopathy
The two papes reviewed here discuss advances in the treatment of of autoimmune nodopathy (AN), a rare neurological condition formerly grouped with chronic inflammatory demyelinating polyradiculoneurop...
26 Apr 17min

Advances in Guillain-Barré Syndrome: Diagnosis, Biomarkers, and Management
This comprehensive medical review examines recent developments in the diagnosis, pathophysiology, and management of Guillain-Barré syndrome (GBS), an autoimmune disorder causing acute paralysis. The a...
26 Apr 20min

GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
This article explores the potential of GLP-1 receptor agonists as a novel treatment for idiopathic intracranial hypertension (IIH), a condition traditionally managed through difficult weight loss and ...
22 Apr 12min

Anti-Amphiphysin Antibody Positive Autoimmune Syndrome
These research sources analyze the clinical profile of anti-amphiphysin-IgG-positive autoimmune syndrome, a rare paraneoplastic condition affecting the nervous system. The documentation highlights div...
20 Apr 19min

Shingles Vaccination and Reduced Dementia Risk
This study examines whether receiving the live-attenuated herpes zoster vaccine reduces the risk of developing dementia among older adults in Canada. Researchers utilized a natural experiment in Ontar...
19 Apr 20min

Approach to Asymptomatic HyperCKemia - EAN Guidelines
The provided text outlines the 2024 European Academy of Neurology (EAN) guidelines for diagnosing adults who exhibit elevated creatine kinase levels without significant symptoms. Because this conditio...
19 Apr 19min

Predictive T-Cell Biomarkers for Checkpoint Inhibitor Response in PML
Progressive multifocal leukoencephalopathy (PML) is a devastating brain infection caused by the JC virus following immune system failure. These sources detail how the virus transforms into a neurotrop...
15 Apr 10min

Practical Strategies for SCIg Maintenance Therapy in CIDP Patients
This clinical research article investigates the effectiveness and practical management of subcutaneous immunoglobulin (SCIg) as a maintenance therapy for individuals with chronic inflammatory demyelin...
13 Apr 17min



















